1. Home
  2. CCS vs INBX Comparison

CCS vs INBX Comparison

Compare CCS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$56.20

Market Cap

1.7B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$91.25

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
INBX
Founded
2000
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
CCS
INBX
Price
$56.20
$91.25
Analyst Decision
Buy
Buy
Analyst Count
5
3
Target Price
$64.80
$150.00
AVG Volume (30 Days)
301.9K
415.9K
Earning Date
04-22-2026
05-15-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$4,117,816,000.00
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.84
N/A
P/E Ratio
$64.38
N/A
Revenue Growth
N/A
550.00
52 Week Low
$47.28
$13.11
52 Week High
$76.00
$155.29

Technical Indicators

Market Signals
Indicator
CCS
INBX
Relative Strength Index (RSI) 56.02 39.16
Support Level $51.57 $71.31
Resistance Level $66.11 $153.14
Average True Range (ATR) 1.93 8.63
MACD 0.68 -3.03
Stochastic Oscillator 97.37 10.92

Price Performance

Historical Comparison
CCS
INBX

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: